The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
Key facts
- Who runs it
- Hvidovre University Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 11 people, planned
- Started
- 3 Jan 2024
- Expected to end
- 1 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Dietary macronutrient composition
- Record updated
- 16 November 2026
Who can take part
- Age
- 35 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Men or women
- 35-75 years old
- BMI >27 kg/m2
- Known type 2 diabetes in stable glucose lowering therapy (for three months) or with HbA1c >48 mmol/mol if no glucose lowering therapy
Who cannot take part
- Treatment with insulin or sulfonylurea
- Treatment with systemic corticosteroids
- Weight loss (>5 kg) within the last three months or previous bariatric surgery
- Thyroid disease if not well controlled based on patient reporting and/or the most recent measurement of TSH
- History of advanced liver fibrosis or cirrhosis
- Food allergies (including lactose and gluten intolerance)
- Anemia (hemoglobin <8 mmol/L for men and <7 mmol/L for women)
- Severely dysregulated diabetes defined by HbA1c >70 mmol/mol
- Kidney failure (eGFR <30 ml/min/1.73 m²) based on patient reporting and/or the most recent control measurement
- Vegetarian/vegan diet or following of specific dietary plans
- Alcohol consumptions >84/168 g/week (women/men)
- Strenuous activity level > 120 minutes per week
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 35 and 75 years old?
This trial is currently available in Denmark.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The primary aim of this randomized cross-over intervention study is to investigate the effect of 16 days of intermittent carbohydrate restriction (alternating between two days of a conventional control diet and, two days of carbohydrate restriction to 10E% (~70-90 grams)) on 24-hour average sensor glucose (primary outcome) in individuals with type 2 diabetes compared with a 16 day control period with a conventional diet. 24-hour average sensor glucose is measured by patient-blinded continuous glucose monitoring (CGM) during the intervention and control period.
The 2 groups in the trial
- Intermittent carbohydrate restrictionTreatment being tested
16 days of intermittent carbohydrate restriction: a controlled dietary regime alternating between two days of restricting carbohydrate intake to 70-90 grams, and two days of a conventional control diet. Protein content is matched between diets. All food is provided.
Treatment: Dietary macronutrient composition
- Control armNo study treatment, for comparison
During the control period (16 days) the macronutrient composition matches that of the non-carbohydrate-restricted days of the intermittent carbohydrate intervention.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06144593, who can take part
- Record updated
- 16 November 2026